This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Merck + Co., Inc.. Active years: 1990.
Company Filing History:
Years Active: 1990
Title: The Innovations of Edgar H. Ulm
Introduction
Edgar H. Ulm is a notable inventor based in Green Lane, PA (US). He has made significant contributions to the field of pharmacology, particularly in the development of anxiolytic agents. With a total of 2 patents, his work has garnered attention in the scientific community.
Latest Patents
Ulm's latest patents include innovative compounds that serve as metabolites of known anxiolytic agents. One of his notable inventions is the 7-chloro-5,6-di, which is a metabolite of the known anxiolytic agent, 7-chloro-5,6-dihydro-3-(5-isopropyl-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4 H-imidazo[1,5a][1,4]benzodiazepine. This compound is recognized as a 1,2-dihydroxy derivative of the isopropyl moiety and exhibits greater activity than its substrate. Another significant patent is the 7-chloro-5,6-dihydro-3-(5-(2-hydroxy-isoprop), which is a 2-hydroxy derivative of the isopropyl moiety and also functions as an anxiolytic agent.
Career Highlights
Edgar H. Ulm is currently associated with Merck & Co., Inc., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing the understanding and effectiveness of anxiolytic treatments.
Collaborations
Ulm has collaborated with esteemed colleagues such as Jiunn H. Lin and Steven M. Pitzenberger. These partnerships have contributed to the successful development of his patented compounds.
Conclusion
Edgar H. Ulm's contributions to the field of pharmacology through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of effective anxiolytic agents.